Carrier particles for dry powder formulations for inhalation

US10709666B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10709666-B2
Application numberUS-202016776020-A
CountryUS
Kind codeB2
Filing dateJan 29, 2020
Priority dateMay 17, 2017
Publication dateJul 14, 2020
Grant dateJul 14, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Carrier particles in the form of granules described herein are suitable for use in dry powder formulations for inhalation, and preferably administering high-strength dose active ingredients.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for preparing a granule of a physiologically acceptable excipient to be used as a carrier for dry powder formulations for inhalation, said granule having a mass diameter of from 200 to 800 micrometers and having on its surface pores with a perimeter from 70 to 300 micrometers and a diameter from 30 to 100 micrometers, a specific surface area of 0.13 to 0.20 m 2 /g, and a loading capacity equal or higher than 35%, wherein said physiologically acceptable excipient is selected from the group consisting of lactose, mannitol, trehalose, dextran, glucose, and mixtures thereof; wherein said granule has a friability of less than 3%, said process comprising the following steps: (i) selecting particles of a physiologically acceptable excipient having a starting median volume diameter of at least 100 micrometers; (ii) preparing an oversaturated aqueous solution comprising part of said physiologically acceptable excipient having a concentration in water of from 30 to 50% w/v; (iii) wetting the remaining part of said physiologically acceptable excipient with 10 to 25% w/w of said aqueous solution obtained in (ii), to obtain a mixture; (iv) stirring said mixture obtain a slurry; (v) forcing said slurry through a sieve, to obtain a wet mass; and (vi) drying said wet mass to obtain said granules. 2. The process according to claim 1 , wherein said (vi) drying is performed in a microwave or in an oven under vacuum.

Assignees

Inventors

Classifications

  • Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin · CPC title

  • substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone · CPC title

  • Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules · CPC title

  • A61K9/145Primary

    with organic compounds · CPC title

  • for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10709666B2 cover?
Carrier particles in the form of granules described herein are suitable for use in dry powder formulations for inhalation, and preferably administering high-strength dose active ingredients.
Who is the assignee on this patent?
Chiesi Farm Spa
What technology area does this patent fall under?
Primary CPC classification A61K9/145. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).